CD274 and gastric cancer: In GC, where tumors often exhibit a highly immunosuppressive TME characterized by low PD‐L1 expression or poor T‐cell infiltration, rendering PD‐1/PD‐L1 inhibitors less effective, the addition of co‐stimulatory receptor agonists holds theoretical appeal.